PHN logo

Pharmanutra S.p.A. Stock Price

BIT:PHN Community·€767.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author

PHN Share Price Performance

€0
-50.20 (-100.00%)
€0
-50.20 (-100.00%)
Price €0

PHN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Outstanding track record with excellent balance sheet.

0 Risks
2 Rewards

Pharmanutra S.p.A. Key Details

€132.2m

Revenue

€65.4m

Cost of Revenue

€66.8m

Gross Profit

€46.8m

Other Expenses

€20.0m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
2.09
50.54%
15.14%
26.7%
View Full Analysis

About PHN

Founded
2000
Employees
128
CEO
n/a
WebsiteView website
www.pharmanutra.it

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for muscle and joint recovery in physiotherapy and sports. The company also sells instrumentation and software for body bioimpedance analysis through agents, distributors, and online sales. Pharmanutra S.p.A. was founded in 2000 and is headquartered in Pisa, Italy.

Recent PHN News & Updates

Recent updates

No updates